Whole Blood Transcriptomics Identifies Differences in Innate Immune Pathway Expression in Infants at Risk for Peanut Allergy. [PDF]
Lang A +7 more
europepmc +1 more source
Design of the Intervention to Reduce Early Peanut Allergy in Children (iREACH): A practice-based clinical trial. [PDF]
Bilaver LA +9 more
europepmc +1 more source
NABIM Wheat allergy and intolerance report [PDF]
MacKenzie, Heather, Venter, Carina
core +1 more source
Risk subgroups and intervention effects among infants at high risk for peanut allergy: A model for clinical decision making. [PDF]
Li Y, Devonshire A, Huang B, Andorf S.
europepmc +1 more source
Development of an innovative curriculum for paediatricians on peanut allergy prevention: How do we address current guidelines? [PDF]
Leeds S +6 more
europepmc +1 more source
Combining avidin with CD63 improves basophil activation test accuracy in classifying peanut allergy. [PDF]
CastaƱo N +18 more
europepmc +1 more source
Sustained silencing peanut allergy by xanthopurpurin is associated with suppression of peripheral and bone marrow IgE-producing B cell. [PDF]
Yang N +11 more
europepmc +1 more source
Different airborne particulates trigger distinct immune pathways leading to peanut allergy in a mouse model. [PDF]
Immormino RM +8 more
europepmc +1 more source
Related searches:
Clinical manifestations of peanut allergy are miscellanous extending from simple itching to anaphylactic shock. They may appear early in life. The diagnosis relies upon history, prick tests, specific IgE dosage, and if necessary oral challenge test. Most often peanut allergy is longstanding requiring a complete exclusion of peanut from the food.
D, de Boissieu, C, Dupont
exaly +10 more sources

